These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28838717)

  • 21. Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.
    Limacher JM; Spring-Giusti C; Bellon N; Ancian P; Rooke R; Bonnefoy JY
    Expert Rev Vaccines; 2013 Mar; 12(3):263-70. PubMed ID: 23496666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
    Socinski MA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
    [No Abstract]   [Full Text] [Related]  

  • 23. Updates on immunotherapy in non-small cell lung cancer.
    Shimanovsky A; Dasanu CA
    Expert Opin Biol Ther; 2014 Apr; 14(4):411-8. PubMed ID: 24512518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.
    Van den Heuvel MM; Burgers SA; van Zandwijk N
    Clin Lung Cancer; 2009 Mar; 10(2):99-105. PubMed ID: 19362952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review.
    Katzman D; Wu S; Sterman DH
    J Thorac Oncol; 2018 May; 13(5):624-635. PubMed ID: 29391289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Take lessons from cancer evolution to the clinic.
    Swanton C
    Nature; 2020 May; 581(7809):382-383. PubMed ID: 32461644
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.
    Carbone DP; Gandara DR; Antonia SJ; Zielinski C; Paz-Ares L
    J Thorac Oncol; 2015 Jul; 10(7):974-84. PubMed ID: 26134219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies.
    Nardone V; Pastina P; Giannicola R; Agostino R; Croci S; Tini P; Pirtoli L; Giordano A; Tagliaferri P; Correale P
    Front Immunol; 2018; 9():2941. PubMed ID: 30619301
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic strategies for the treatment of non-small cell lung cancer.
    Yano T; Yoshino I; Baba H; Tomiyasu M; Fukuyama S; Sugimachi K
    Surgery; 2002 Jan; 131(1 Suppl):S232-5. PubMed ID: 11821817
    [No Abstract]   [Full Text] [Related]  

  • 30. How I treat stage IV non-small cell lung cancer in the absence of any actionable oncogenic driver.
    Socinski MA
    Clin Adv Hematol Oncol; 2017 Oct; 15(10):759-765. PubMed ID: 29040255
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune-based Therapies for Non-small Cell Lung Cancer.
    Rafei H; El-Bahesh E; Finianos A; Nassereddine S; Tabbara I
    Anticancer Res; 2017 Feb; 37(2):377-387. PubMed ID: 28179283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Lingering Questions in Immunotherapy.
    Wright K
    Oncology (Williston Park); 2020 Mar; 34(3):. PubMed ID: 32212135
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives.
    Rice SJ; Miller B; Wagman M; Jamorabo DS; Liu X; Belani CP
    Curr Mol Pharmacol; 2016; 9(3):183-195. PubMed ID: 26177648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New strategies in lung cancer: translating immunotherapy into clinical practice.
    Forde PM; Kelly RJ; Brahmer JR
    Clin Cancer Res; 2014 Mar; 20(5):1067-73. PubMed ID: 24470514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Belagenpumatucel-L for the treatment of non-small cell lung cancer.
    Rijavec E; Biello F; Genova C; Barletta G; Maggioni C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F
    Expert Opin Biol Ther; 2015; 15(9):1371-9. PubMed ID: 26211534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer.
    Roviello G; Vascotto IA; Catalano M
    Front Immunol; 2024; 15():1415608. PubMed ID: 38726009
    [No Abstract]   [Full Text] [Related]  

  • 38. Understanding the Rationale for Immunotherapy in Non-Small Cell Lung Cancer.
    Pennell NA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S3-10. PubMed ID: 26477472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.
    Ramlau R; Quoix E; Rolski J; Pless M; Lena H; Lévy E; Krzakowski M; Hess D; Tartour E; Chenard MP; Limacher JM; Bizouarne N; Acres B; Halluard C; Velu T
    J Thorac Oncol; 2008 Jul; 3(7):735-44. PubMed ID: 18594319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer.
    Daly ME; Monjazeb AM; Kelly K
    J Thorac Oncol; 2015 Dec; 10(12):1685-93. PubMed ID: 26484629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.